Likewise, VEGF in combination with IL10 and prostaglandin E2 (PGE2) promotes a tumor endothelial ‘death barrier’ that is established by Fas-L expression to exclude CD8+ T cells preferentially over Tregs [83]. Here, VEGFA is linked to neoplasm.